TrialLeukemia2017

Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.

J Edelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.